Researchers have engineered probiotic bacteria to produce CRISPR-Cas9 and edit the ROS-generating NOX2/gp91phox target in mouse intestinal cells. The...
A recent proof-of-concept study has brought prime editing one step closer to clinical trials. Dr. Dong Hyun Jo explains how he and his colleagues...
